Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.57 |
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.57 |
| ▸ | CA7 | P43166 | 1/20 | 0.57 |
| ▸ | CA9 | Q16790 | 1/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.57 |
| ▸ | AKR1C3 | P42330 | 7/20 | 0.54 |
| ▸ | AKR1C2 | P52895 | 7/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KDR | P35968 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | TNF | P01375 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29955411 | 1.00 | CSNK2A1 (0.59) | CSNK2A1CA1CA2PTGS2CA12 | |
| SCHEMBL7295677 | 0.87 | PKM (0.57) | AKR1C3AKR1C2PKMHTT | |
| SCHEMBL8123713 | 0.85 | RXRA (0.53) | CA1CA2PTGS2CA12CA7 | |
| SCHEMBL330378 | 0.85 | KDM4E (0.67) | CSNK2A1CA1CA2PTGS2CA12 | |
| SCHEMBL30268239 | 0.85 | KDM4E (0.67) | CSNK2A1CA1CA2PTGS2CA12 | |
| SCHEMBL3183624 | 0.84 | PKM (0.50) | CSNK2A1CA1CA2PTGS2CA12 | |
| SCHEMBL3839830 | 0.83 | ALDH1A1 (0.57) | CA1CA2PTGS2CA12CA7 | |
| SCHEMBL29956901 | 0.83 | KDM4E (0.59) | CSNK2A1CA1CA2PTGS2CA12 | |
| SCHEMBL1162134 | 0.83 | KDM4E (0.59) | CSNK2A1CA1CA2PTGS2CA12 | |
| SCHEMBL7823608 | 0.83 | CDC25A (0.59) | AKR1C3AKR1C2KDM4EHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 347 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119924314-A | Neutral peroxyacetic acid disinfectant for endoscope disinfection | 山东新华医疗器械股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | claimed |
| CN-109678707-A | A kind of deuterium-labeled D3The synthetic method of salbutamol | 东莞暨南大学研究院 | 2019-04-26 | — | — | CN | claimed |
| US-10191398-B2 | Electrophotographic photoconductor, image forming apparatus, and process cartridge | RICOH COMPANY, LTD. (JP) | 2019-01-29 | — | — | US | claimed |
| EP-1429768-B1 | NOVEL MEDICAMENTS FOR INHALATION | BOEHRINGER INGELHEIM PHARMA (DE) | 2016-11-16 | — | — | EP | claimed |
| US-20130315998-A1 | Topical Foam Composition | CIPLA LIMITED (IN) | 2013-11-28 | — | — | US | claimed |
| US-20130202654-A1 | Topical Foam Composition | CIPLA LIMITED (IN) | 2013-08-08 | — | — | US | claimed |
| EP-2503989-A2 | TOPICAL FOAM COMPOSITION | Cipla Limited (IN) | 2012-10-03 | — | — | EP | claimed |
| EP-2503988-A2 | TOPICAL FOAM COMPOSITION | Cipla Limited (IN) | 2012-10-03 | — | — | EP | claimed |
| WO-2011061516-A2 | TOPICAL FOAM COMPOSITION | CIPLA LIMITED (IN) | 2011-05-26 | — | — | WO | claimed |
| US-20030180250-A1 | Compositions and complexes containing a macromolecular compound as potential anti-inflammatory agents | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2003-09-25 | — | — | US | claimed |
| US-20030130300-A1 | Respiratory system disorders; synergistic mixtures | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-07-10 | — | — | US | claimed |
| WO-2003024452-A1 | NOVEL MEDICAMENTS FOR INHALATION | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2003-03-27 | — | — | WO | claimed |
| EP-1131058-A1 | LOCAL DELIVERY OF DRUGS TO THE COLON FOR LOCAL TREATMENT OF COLONIC DISEASES | Dexxon Ltd. (IL) | 2001-09-12 | — | — | EP | claimed |
| US-6231888-B1 | DRUG DELIVERY FOR DRUGS WITH CORES AND COATINGS | PERIO PRODUCTS LTD. (IL) | 2001-05-15 | — | — | US | claimed |
| EP-0763010-B1 | ENANTIOSELECTIVE PREPARATION OF OPTICALLY PURE ALBUTEROL | SEPRACOR INC (US) | 2000-08-30 | — | — | EP | claimed |
| WO-2000028974-A1 | LOCAL DELIVERY OF DRUGS TO THE COLON FOR LOCAL TREATMENT OF COLONIC DISEASES | DEXXON LTD. (IL) | 2000-05-25 | — | — | WO | claimed |
| WO-1994014750-A1 | NOVEL SALICYLIC ACID DERIVATIVES, THEIR SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME | Richter Gedeon Vegyészeti Gyár Rt. (HU) | 1994-07-07 | — | — | WO | claimed |
| EP-0383406-A1 | A process for encapsulating an active ingredient | UNILEVER N.V. (NL) | 1990-08-22 | — | — | EP | claimed |
| US-4118401-A | Preparation of 6,11-dihydro-11-oxodibenz[b,e]oxepin-2-acetic acid and precursors therefor | AMERICAN HOECHST CORPORATION (US) | 1978-10-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030180250-A1 | Compositions and complexes containing a macromolecular compound as potential anti-inflammatory agents | CD68, MPO, MIF | CSNK2A1 1448/4885CA1 3502/4885CA2 4055/4885 |
| US-20130202654-A1 | Topical Foam Composition | LPXN, RFTN1, RDX | CSNK2A1 1838/4885CA1 4651/4885CA2 4710/4885 |
| US-20030130300-A1 | Respiratory system disorders; synergistic mixtures | ADRB3, ADRB1, CHRM3 | CSNK2A1 1450/4885CA1 2913/4885CA2 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.